Related Experiment Videos
Human diabetic perineurial cell basement membrane thickening
Summary
Diabetic peripheral nerves show thickened perineurial cell basement membranes compared to healthy nerves. This thickening is more pronounced in diabetics using insulin, suggesting a potential diagnostic marker for diabetic neuropathy.
Area of Science:
- Neuroscience
- Cell Biology
- Diabetology
Background:
- The perineurium, a cellular sheath of peripheral nerves, isolates the endoneurium from the epineurium.
- Perineurial cells are enveloped by basement membranes on both inner and outer surfaces.
- Diabetic microvasculature is known to exhibit basement membrane thickening.
Purpose of the Study:
- To investigate ultrastructural thickness of human sural nerve perineurial cell basement membranes.
- To compare basement membrane thickness in diabetic and non-diabetic individuals.
- To assess the impact of insulin treatment on basement membrane thickness in diabetics.
Main Methods:
- Ultrastructural thickness measurements of perineurial cell basement membranes from human sural nerves.
- Comparison of measurements between diabetic patients and non-diabetic controls.
- Subgroup analysis of diabetic patients based on insulin treatment status.
Main Results:
- Diabetic patients (n=24) exhibited significantly greater mean perineurial cell basement membrane thickness (174.1 ± 76.2 nm) than non-diabetics (n=19) (67.1 ± 12.8 nm; p < 0.001).
- Diabetics on insulin (n=13) showed further exaggerated thickening (208.4 ± 78.1 nm) compared to those not on insulin (133.5 ± 51.8 nm; p = 0.01).
- No significant differences were found based on sex or tissue source (autopsy vs. biopsy).
Conclusions:
- Diabetes mellitus is associated with thickening of the perineurial cell basement membrane, a non-vascular component of peripheral nerves.
- Insulin treatment in diabetics exacerbates this perineurial basement membrane thickening.
- Quantitation of perineurial cell basement membrane thickness may serve as a valuable biomarker for distinguishing diabetic from non-diabetic distal symmetrical neuropathy.